Literature DB >> 17476148

Elective oophorectomy for benign gynecological disorders.

Donna Shoupe1, William H Parker, Michael S Broder, Zhimei Liu, Cindy Farquhar, Jonathan S Berek.   

Abstract

OBJECTIVE: To review the risks and benefits of elective oophorectomy and to make a clinical recommendation for an appropriate age when benefits of this procedure outweigh the risks.
DESIGN: The risks and benefits of oophorectomy as detailed in published articles are reviewed with regard to quality-of-life issues and mortality outcomes in oophorectomized versus non-oophorectomized women from five diseases linked to ovarian hormones (coronary heart disease, ovarian cancer, breast cancer, stroke, and hip fracture).
RESULTS: Numerous reports link oophorectomy to higher rates of cardiovascular disease, osteoporosis, hip fractures, dementia, short-term memory impairment, decline in sexual function, decreased positive psychological well-being, adverse skin and body composition changes, and adverse ocular changes, as well as more severe hot flushes and urogenital atrophy. The potential benefits associated with oophorectomy include prevention of ovarian cancer, a decline in breast cancer risk, and a reduced risk of pelvic pain and subsequent ovarian surgery. In our study of long-term mortality after oophorectomy using Markov modeling, preservation of ovaries until women are at least aged 65 years was associated with higher survival rates. For women between ages 50 and 54 with hysterectomy and ovarian preservation, the probability of surviving to age 80 was 62% versus 54% if oophorectomy was performed. This 8% difference in survival is primarily due to fewer women dying from cardiovascular heart disease and/or hip fracture. This survival advantage far outweighs the 0.47% increased mortality rate from ovarian cancer prevented by oophorectomy. If surgery occurred between ages 55 and 59, the survival advantage was 4%. After age 64 there were no significant differences in survival rates. Prior literature supports our conclusion of a benefit over risk for ovarian conservation.
CONCLUSIONS: Elective oophorectomy is associated with short-and long-term health consequences that merit serious consideration. For women with an average risk of ovarian cancer, ovarian conservation until at least age 65 seems to benefit long-term survival.

Entities:  

Mesh:

Year:  2007        PMID: 17476148     DOI: 10.1097/gme.0b013e31803c56a4

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  14 in total

1.  Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.

Authors:  Koji Matsuo; James C Cripe; Katherine C Kurnit; Michiko Kaneda; Audrey S Garneau; Gretchen E Glaser; Aaron Nizam; Rachel M Schillinger; Michelle L Kuznicki; Akira Yabuno; Shiori Yanai; Denise M Garofalo; Jiro Suzuki; Jessica D St Laurent; Ting-Tai Yen; Annie Y Liu; Masako Shida; Mamoru Kakuda; Tetsuro Oishi; Shin Nishio; Jenna Z Marcus; Sosuke Adachi; Tetsuji Kurokawa; Malcolm S Ross; Max P Horowitz; Marian S Johnson; Min K Kim; Alexander Melamed; Karime K Machado; Kosuke Yoshihara; Yoshio Yoshida; Takayuki Enomoto; Kimio Ushijima; Shinya Satoh; Yutaka Ueda; Mikio Mikami; Bobbie J Rimel; Rebecca L Stone; Whitfield B Growdon; Aikou Okamoto; Saketh R Guntupalli; Kosei Hasegawa; Mian M K Shahzad; Dwight D Im; Marina Frimer; Bobbie S Gostout; Frederick R Ueland; Shoji Nagao; Pamela T Soliman; Premal H Thaker; Jason D Wright; Lynda D Roman
Journal:  Gynecol Oncol       Date:  2019-08-16       Impact factor: 5.482

2.  Negative attitudes and affect do not predict elective hysterectomy: a prospective analysis from the Study of Women's Health Across the Nation.

Authors:  Carolyn J Gibson; Joyce T Bromberger; Gerson E Weiss; Rebecca C Thurston; MaryFran Sowers; Karen A Matthews
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

Review 3.  Salpingectomy as a means to reduce ovarian cancer risk.

Authors:  Mary B Daly; Charles W Dresher; Melinda S Yates; Joanne M Jeter; Beth Y Karlan; David S Alberts; Karen H Lu
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

Review 4.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

5.  Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study.

Authors:  Lei Duan; Xinxin Xu; Corinna Koebnick; James V Lacey; Jane Sullivan-Halley; Claire Templeman; Sarah F Marshall; Susan L Neuhausen; Giske Ursin; Leslie Bernstein; Katherine D Henderson
Journal:  Fertil Steril       Date:  2011-11-14       Impact factor: 7.329

6.  Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?

Authors:  Hazel B Nichols; Kala Visvanathan; Polly A Newcomb; John M Hampton; Kathleen M Egan; Linda Titus-Ernstoff; Amy Trentham-Dietz
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

Review 7.  An overview of optical coherence tomography for ovarian tissue imaging and characterization.

Authors:  Tianheng Wang; Molly Brewer; Quing Zhu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-20

8.  Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.

Authors:  Walter A Rocca; Lynne T Shuster; Brandon R Grossardt; Demetrius M Maraganore; Bobbie S Gostout; Yonas E Geda; L Joseph Melton
Journal:  Womens Health (Lond)       Date:  2009-01

9.  Increased cardiovascular mortality after early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Robert D Brown; Véronique L Roger; L Joseph Melton; Walter A Rocca
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

Review 10.  Prophylactic oophorectomy in premenopausal women and long-term health.

Authors:  Lynne T Shuster; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Menopause Int       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.